Discovers, develops and commercializes life-changing cancer therapies. Fueled by a belief in the extraordinary strength and courage of patients.Karyopharm Therapeutics is an innovation-driven pharmaceutical company focused on the discovery, development, and commercialization of medicines with the goal of improving the lives of patients with cancer.

Core values

- **Addressing Societal Needs**: The company is dedicated to the discovery, development, and commercialization of novel cancer therapies, which addresses a significant societal need for effective cancer treatments[2][5].
- **Improving Quality of Life**: Karyopharm's drug, selinexor (XPOVIO), has shown to improve health-related quality of life parameters and reduce the time to disease progression or death in various cancer indications, such as multiple myeloma and diffuse large B-cell lymphoma[3][5].
- **Promoting Positive Change**: The company's efforts, particularly through advocacy and patient education, help bridge the gap between patients and healthcare providers, enhancing patient preparedness and advocacy[1].
- **Contributing to Community Well-being**: Karyopharm's work, especially in addressing health disparities and supporting patient communities, contributes positively to community well-being, particularly in marginalized communities[1].